Article
Immunology
Yoojoong Jung, Jin-Young Min, Hye-Jin Kim, Kyoug-Bok Min
Summary: This study aimed to compare infant mortality rates from all-infectious diseases, vaccine-preventable diseases and non-vaccine-preventable diseases by mother's and father's education levels. Results showed that higher parents' education level was appreciably associated with lower infant mortality from all cause, all-infectious diseases, vaccine-preventable diseases, and non-vaccine-preventable diseases. Moreover, each mother's and father's education level was correlated to infant mortality due to vaccine-preventable diseases on the whole education level.
Review
Immunology
Tran Duc Anh Ly, Sergei Castaneda, Van Thuan Hoang, Thi Loi Dao, Philippe Gautret
Summary: The study revealed a high burden of vaccine-preventable diseases among homeless populations, highlighting the importance of establishing a national vaccination program. Factors positively associated with HBV and HAV infections include age, behaviors, and sexual partner history.
Review
Immunology
Ma'mon M. Hatmal, Mohammad A. Al-Hatamleh, Amin N. Olaimat, Suhana Ahmad, Hanan Hasan, Nurfatihah Azlyna Ahmad Suhaimi, Khaled A. Albakri, Anas Abedalbaset Alzyoud, Ramlah Kadir, Rohimah Mohamud
Summary: The current outbreak of monkeypox has raised global concern. Monkeypox, caused by the MPX virus, is similar to smallpox and can be prevented by smallpox vaccines and drugs. This review summarizes the available data on the virus and its major biological, clinical, and epidemiological aspects, aiming to raise awareness, control the outbreak, and improve healthcare services and hygiene practices.
EMERGING MICROBES & INFECTIONS
(2022)
Review
Clinical Neurology
Emira Hodzic, Rodrigo Hasbun, Alejandro Granillo, Anna R. Troescher, Helga Wagner, Tim J. von Oertzen, Judith N. Wagner
Summary: This study presents a systematic review and meta-analysis on the use of steroids in viral encephalitis (VE), finding that there is no clear therapeutic effect of steroid treatment in VE patients.
JOURNAL OF NEUROLOGY
(2023)
Article
Immunology
Nicola Principi, Susanna Esposito
Summary: The rapid development of numerous vaccines for COVID-19 has mainly focused on healthy adults and, to a lesser extent, the elderly, with limited involvement of children. However, the urgent need for a safe and effective pediatric vaccine highlights the necessity for strong collaboration among governments, researchers, and pharmaceutical companies.
Article
Immunology
Kaatje Bollaerts, Mark A. Fletcher, Jose A. Suaya, Germaine Hanquet, Marc Baay, Bradford D. Gessner
Summary: Vaccine regulatory decision making based on pathogenically confirmed outcomes may underestimate the preventable disease burden. Comparing clinically defined outcomes with radiologically/etiologically confirmed outcomes, we found that clinically defined outcomes provide a more accurate estimate of the public health value of pneumococcal conjugate vaccines.
CLINICAL INFECTIOUS DISEASES
(2022)
Review
Infectious Diseases
Sarah C. J. Jorgensen, Simona Miljanic, Najla Tabbara, Deborah Somanader, Christopher L. Y. Tse, Charmaine De Castro, Isabelle Malhame, Stephen E. LapinskY, Lisa Burry
Summary: This study demonstrates the widespread exclusion of pregnant and breastfeeding people from randomized controlled trials (RCTs) evaluating interventions for infectious diseases.
CLINICAL MICROBIOLOGY AND INFECTION
(2022)
Article
Public, Environmental & Occupational Health
C. Arango-Usuga, J. Ochoa, A. Leon, D. Hincapie-Palacio
Summary: This study describes the trends in mortality from eight vaccine-preventable diseases in Colombia over the past 40 years and examines their relationship with vaccination coverage. The results show that the number of deaths and adjusted rates have decreased since 1989 in all diseases. Vaccination coverage below 90% is associated with an increase in mortality from certain diseases.
Review
Obstetrics & Gynecology
E. Joubert, A. C. Kekeh, C. N. Amin
Summary: This article provides a literature review on the current status of COVID-19 vaccination for pregnant and lactating individuals, aiming to assist them and healthcare providers in making informed decisions.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
(2022)
Review
Oncology
Miaojin Zhu, Jia Ji, Danrong Shi, Xiangyun Lu, Baohong Wang, Nanping Wu, Jie Wu, Hangping Yao, Lanjuan Li
Summary: Monkeypox, caused by the monkeypox virus, has become a global concern during the ongoing COVID-19 pandemic. The re-emergence of this virus and outbreaks in multiple nonendemic countries require attention and control measures.
FRONTIERS OF MEDICINE
(2022)
Review
Public, Environmental & Occupational Health
Bayissa Chala, Feyissa Hamde
Summary: Vector-borne emerging and re-emerging diseases pose significant public health challenges globally. Interactions among pathogens, hosts, environment, and social demographic factors are key to the emergence and re-emergence of these diseases. Ongoing evolution of pathogens, population growth, urbanization, and climate change are among the factors linked with the appearance and resurgence of vector-borne infectious diseases.
FRONTIERS IN PUBLIC HEALTH
(2021)
Review
Computer Science, Information Systems
Javier Antonio Ballesteros-Ricaurte, Ramon Fabregat, Angela Carrillo-Ramos, Carlos Parra, Martin Orlando Pulido-Medellin
Summary: This article is a systematic literature review on models used in the epidemiological analysis of bovine infectious diseases in the dairy farming sector. The review presents the relationships between the different models and bovine infectious diseases, as well as the techniques used and the works on infectious diseases in humans. The outcomes of this review provide up-to-date inputs for research on models for the epidemiological analysis of infectious bovine diseases, and introduce an adaptive and predictive system for the bovine ecosystem.
Review
Health Care Sciences & Services
Ivy Y. Zhao, Ye Xuan Ma, Man Wai Cecilia Yu, Jia Liu, Wei Nan Dong, Qin Pang, Xiao Qin Lu, Alex Molassiotis, Eleanor Holroyd, Chi Wai William Wong
Summary: This study investigates ethical issues related to using artificial intelligence-augmented surveillance systems for early detection and monitoring of infectious diseases. Ethical considerations include issues such as digital surveillance awareness, integrity, trust, privacy, civil rights, and governance at individual, organizational, and societal levels. The findings emphasize the importance of addressing these ethical concerns in the deployment of digital surveillance systems for infectious disease monitoring and detection.
JOURNAL OF MEDICAL INTERNET RESEARCH
(2021)
Review
Biology
Tingting Li, Ciying Qian, Ying Gu, Jun Zhang, Shaowei Li, Ningshao Xia
Summary: This article provides an overview of recent advances in the development of both conventional prophylactic vaccines and therapeutic vaccines. It covers different vaccine forms and their applications in various diseases. The aim is to offer new insights and technologies for future vaccine design.
SCIENCE CHINA-LIFE SCIENCES
(2023)
Article
Health Care Sciences & Services
Qiangsong Wu, Maryam Zaid, Zeliang Xuan, Chenxi Wang, Haiyan Gu, Min Shi, Jiahui Zhu, Yi Hu, Jingyi Liu
Summary: This study assessed the impact of national vaccination strategies on vaccine-preventable infectious diseases in Shanghai, China, showing a decreasing trend in incidence, mortality, and fatality of VPDs over the three eras. However, there was an increasing trend in overall yearly incidence of VPDs from 2000 to 2018. Focus is needed on controlling adult hepatitis and tuberculosis, while research and promotion of vaccines for varicella and HFMD are essential.
LANCET REGIONAL HEALTH-WESTERN PACIFIC
(2021)
Article
Health Care Sciences & Services
Alan Girling, Richard Lilford, Amanda Cole, Terry Young
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
(2015)
Article
Economics
Luis Hernandez, Shien Guo, Hector Toro-Diaz, Stuart Carroll, Syed Feisal Syed Farooq
JOURNAL OF MEDICAL ECONOMICS
(2017)
Review
Economics
Emma Cowles, Grace Marsden, Amanda Cole, Nancy Devlin
APPLIED HEALTH ECONOMICS AND HEALTH POLICY
(2017)
Article
Oncology
Seye Abogunrin, Gian Luca Di Tanna, Sam Keeping, Stuart Carroll, Ike Iheanacho
Article
Health Care Sciences & Services
Mick Serpell, Adam Gater, Stuart Carroll, Linda Abetz-Webb, Azharul Mannan, Robert Johnson
HEALTH AND QUALITY OF LIFE OUTCOMES
(2014)
Review
Immunology
Victoria A. H. Coles, Ajay S. Patel, Felicity L. Allen, Sam T. Keeping, Stuart M. Carroll
INTERNATIONAL JOURNAL OF STD & AIDS
(2015)
Review
Economics
A. Chapman, C. Taylor, A. Girling
APPLIED HEALTH ECONOMICS AND HEALTH POLICY
(2014)
Article
Public, Environmental & Occupational Health
Joe W. E. Moss, Craig Davidson, Richard Mattock, Ilana Gibbons, Stuart Mealing, Stuart Carroll
Article
Environmental Sciences
Denis Horgan, Bettina Borisch, Ivana Cattaneo, Mark Caulfield, Arturo Chiti, Christine Chomienne, Amanda Cole, Karen Facey, Allan Hackshaw, Minna Hendolin, Nadia Georges, Dipak Kalra, Birute Tumiene, Martina von Meyenn
Summary: The potential of real-world data to improve healthcare research, delivery of care, and patient outcomes is recognized, but it requires frameworks for public trust and data access, cross-border governance, alignment of evidence frameworks, and addressing challenges in data curation.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Article
Immunology
Eleanor Bell, Simon Brassel, Edward Oliver, Hannah Schirrmacher, Sofie Arnetorp, Katja Berg, Duncan Darroch-Thompson, Paula Pohja-Hutchison, Bruce Mungall, Stuart Carroll, Maarten Postma, Lotte Steuten
Summary: This research provides an overview of the global burden of COVID-19 and estimates the value of access to COVID-19 vaccines. Low-income countries allocate more resources to COVID-19 compared to high-income countries, and all countries experience lower than predicted economic growth. If all eligible countries achieve broader and more equitable access, more deaths could be averted and substantial healthcare savings could be achieved. The cost to high-income countries of not vaccinating all countries far exceeds the cost of global vaccine manufacturing and distribution.
Article
Economics
Richard Mattock, Ilana Gibbons, Joe Moss, Stuart Mealing, Nathalie Largeron, Stuart Carroll, Fabian P. Alvarez
Summary: The cost-effectiveness analysis showed that in the 65+ population in England and Wales, using HD TIV instead of aTIV has better clinical benefits and economic outcomes. HD TIV can reduce the number of influenza cases, deaths, hospitalizations, and GP appointments.
JOURNAL OF MEDICAL ECONOMICS
(2021)
Review
Microbiology
James Clark-Wright, Pollyanna Hudson, Conor McCloskey, Stuart Carroll
FUTURE MICROBIOLOGY
(2020)
Article
Economics
Amanda Cole, Koonal Shah, Brendan Mulhern, Yan Feng, Nancy Devlin
EUROPEAN JOURNAL OF HEALTH ECONOMICS
(2018)